150 related articles for article (PubMed ID: 36271952)
1. Construction of a combined random forest and artificial neural network diagnosis model to screening potential biomarker for hepatoblastoma.
Liu S; Zheng Q; Zhang R; Li T; Zhan J
Pediatr Surg Int; 2022 Dec; 38(12):2023-2034. PubMed ID: 36271952
[TBL] [Abstract][Full Text] [Related]
2. Cross talk between RNA N6-methyladenosine methyltransferase-like 3 and miR-186 regulates hepatoblastoma progression through Wnt/β-catenin signalling pathway.
Cui X; Wang Z; Li J; Zhu J; Ren Z; Zhang D; Zhao W; Fan Y; Zhang D; Sun R
Cell Prolif; 2020 Mar; 53(3):e12768. PubMed ID: 31967701
[TBL] [Abstract][Full Text] [Related]
3. Identification of Ten Core Hub Genes as Potential Biomarkers and Treatment Target for Hepatoblastoma.
Sun R; Li S; Zhao K; Diao M; Li L
Front Oncol; 2021; 11():591507. PubMed ID: 33868991
[TBL] [Abstract][Full Text] [Related]
4. Integrative Analysis of DNA Methylation and Gene Expression Profiling Data Reveals Candidate Methylation-Regulated Genes in Hepatoblastoma.
Wang JY; Lao J; Luo Y; Guo JJ; Cheng H; Zhang HY; Yao J; Ma XP; Wang B
Int J Gen Med; 2021; 14():9419-9431. PubMed ID: 34908869
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of SFRP1 is a protumorigenic event in hepatoblastoma and correlates with beta-catenin mutations.
Regel I; Eichenmüller M; Mahajan UM; Hagl B; Benitz S; Häberle B; Vokuhl C; von Schweinitz D; Kappler R
J Cancer Res Clin Oncol; 2020 May; 146(5):1153-1167. PubMed ID: 32189106
[TBL] [Abstract][Full Text] [Related]
6. Cytomorphology of hepatoblastoma with histological correlation and role of SALL4 immunocytochemistry in its diagnosis, subtyping, and prognostication.
Nakra T; Roy M; Yadav R; Agarwala S; Jassim M; Khanna G; Das P; Jain D; Mathur SR; Iyer VK
Cancer Cytopathol; 2020 Mar; 128(3):190-200. PubMed ID: 31880869
[TBL] [Abstract][Full Text] [Related]
7. Exome sequencing of hepatoblastoma reveals novel mutations and cancer genes in the Wnt pathway and ubiquitin ligase complex.
Jia D; Dong R; Jing Y; Xu D; Wang Q; Chen L; Li Q; Huang Y; Zhang Y; Zhang Z; Liu L; Zheng S; Xia Q; Wang H; Dong K; He X
Hepatology; 2014 Nov; 60(5):1686-96. PubMed ID: 24912477
[TBL] [Abstract][Full Text] [Related]
8. Should children at risk for familial adenomatous polyposis be screened for hepatoblastoma and children with apparently sporadic hepatoblastoma be screened for APC germline mutations?
Aretz S; Koch A; Uhlhaas S; Friedl W; Propping P; von Schweinitz D; Pietsch T
Pediatr Blood Cancer; 2006 Nov; 47(6):811-8. PubMed ID: 16317745
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications.
Carrillo-Reixach J; Torrens L; Simon-Coma M; Royo L; Domingo-Sàbat M; Abril-Fornaguera J; Akers N; Sala M; Ragull S; Arnal M; Villalmanzo N; Cairo S; Villanueva A; Kappler R; Garrido M; Guerra L; Sábado C; Guillén G; Mallo M; Piñeyro D; Vázquez-Vitali M; Kuchuk O; Mateos ME; Ramírez G; Santamaría ML; Mozo Y; Soriano A; Grotzer M; Branchereau S; de Andoin NG; López-Ibor B; López-Almaraz R; Salinas JA; Torres B; Hernández F; Uriz JJ; Fabre M; Blanco J; Paris C; Bajčiová V; Laureys G; Masnou H; Clos A; Belendez C; Guettier C; Sumoy L; Planas R; Jordà M; Nonell L; Czauderna P; Morland B; Sia D; Losic B; Buendia MA; Sarrias MR; Llovet JM; Armengol C
J Hepatol; 2020 Aug; 73(2):328-341. PubMed ID: 32240714
[TBL] [Abstract][Full Text] [Related]
10. Exosomal miR-34s panel as potential novel diagnostic and prognostic biomarker in patients with hepatoblastoma.
Jiao C; Jiao X; Zhu A; Ge J; Xu X
J Pediatr Surg; 2017 Apr; 52(4):618-624. PubMed ID: 28277300
[TBL] [Abstract][Full Text] [Related]
11. [Screening and identification of apolipoprotein A-I as a potential marker for hepatoblastoma in children].
Guo LH; Zhao W; Zhang JJ; Zhang Q; Fan YZ; Wang JX
Zhongguo Dang Dai Er Ke Za Zhi; 2016 Dec; 18(12):1205-1210. PubMed ID: 27974108
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of dishevelled-2 inhibits cell proliferation and invasion in hepatoblastoma.
Huang S; Chen J; Tian R; Wang J; Xie C; Gao H; Shan Y; Hong J; Zhang Z; Xu M; Gu S
Pediatr Blood Cancer; 2018 Jul; 65(7):e27032. PubMed ID: 29528187
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of
Beck A; Trippel F; Wagner A; Joppien S; Felle M; Vokuhl C; Schwarzmayr T; Strom TM; von Schweinitz D; Längst G; Kappler R
Clin Epigenetics; 2018; 10():27. PubMed ID: 29507645
[TBL] [Abstract][Full Text] [Related]
14. Detection of Serum Protein Biomarkers for the Diagnosis and Staging of Hepatoblastoma.
Zhao W; Li J; Zhang J; Gao P; Pei H; Wang L; Guo F; Yu J; Zheng S; Wang J
Int J Mol Sci; 2015 Jun; 16(6):12669-85. PubMed ID: 26053398
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and prognostic values of serum exosomal microRNA-21 in children with hepatoblastoma: a Chinese population-based study.
Liu W; Chen S; Liu B
Pediatr Surg Int; 2016 Nov; 32(11):1059-1065. PubMed ID: 27601233
[TBL] [Abstract][Full Text] [Related]
16. Transcription activation of circ-STAT3 induced by Gli2 promotes the progression of hepatoblastoma via acting as a sponge for miR-29a/b/c-3p to upregulate STAT3/Gli2.
Liu Y; Song J; Liu Y; Zhou Z; Wang X
J Exp Clin Cancer Res; 2020 Jun; 39(1):101. PubMed ID: 32493490
[TBL] [Abstract][Full Text] [Related]
17. A novel tissue-based ß-catenin gene and immunohistochemical analysis to exclude familial adenomatous polyposis among children with hepatoblastoma tumors.
Dubbink HJ; Hollink IHIM; Avenca Valente C; Wang W; Liu P; Doukas M; van Noesel MM; Dinjens WNM; Wagner A; Smits R
Pediatr Blood Cancer; 2018 Jun; 65(6):e26991. PubMed ID: 29446530
[TBL] [Abstract][Full Text] [Related]
18. ARID1B/SUB1-activated lncRNA HOXA-AS2 drives the malignant behaviour of hepatoblastoma through regulation of HOXA3.
Liu G; Liu B; Liu X; Xie L; He J; Zhang J; Dong R; Ma D; Dong K; Ye M
J Cell Mol Med; 2021 Apr; 25(7):3524-3536. PubMed ID: 33683826
[TBL] [Abstract][Full Text] [Related]
19. Exploration of Potential Biomarkers and Immune Landscape for Hepatoblastoma: Evidence from Machine Learning Algorithm.
Zhou P; Gao S; Hu B
Evid Based Complement Alternat Med; 2022; 2022():2417134. PubMed ID: 35958911
[TBL] [Abstract][Full Text] [Related]
20. HGF/c-Met related activation of β-catenin in hepatoblastoma.
Purcell R; Childs M; Maibach R; Miles C; Turner C; Zimmermann A; Sullivan M
J Exp Clin Cancer Res; 2011 Oct; 30(1):96. PubMed ID: 21992464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
